This new research indicates that while there are ongoing trials seeking to define which individuals with subsegmental PE may be surveilled, greater uptake of newer surveillance actions may necessitate more than passive diffusion.
This randomized clinical trial evaluates the benefits and risks of the addition of a P2Y12 inhibitor to anticoagulant therapy compared with anticoagulant therap
/PRNewswire/ Versiti has been granted three multi-center research contracts to coordinate nationwide clinical trials aimed at establishing optimal treatment.